Stay updated with breaking news from Lara Longpre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jump Financial LLC increased its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 607.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,384 shares of the company’s stock after purchasing an additional 75,024 shares during the quarter. Jump […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the transaction, the insider now owns 105,254 shares of the company’s stock, valued […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the sale, the insider now directly owns 105,254 shares of the company’s stock, […]
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by investment analysts at JMP Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $64.00 price objective on the stock. JMP Securities’ price objective points to a potential upside of 142.15% from […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $31.00, but opened at $32.28. Mirum Pharmaceuticals shares last traded at $32.35, with a volume of 70,778 shares changing hands. Analyst Upgrades and Downgrades Several equities analysts recently commented on MIRM […]